IHC antibody for Esophagus Cancer

Immunohistochemical techniques is a methodology which based on antigen-antibody immunological response to its theoretical foundation. It plays an important role in basic and clinical medical research in the field of biology, especially in the diagnosis of diseases of the tumors, differential diagnosis and pathogenesis research provides a powerful tool. With the development of new technologies, hundreds of kinds of antibodies used in various areas of clinical research, the majority of these antibodies play an important supporting role in the diagnosis of difficult cases. It has important implications for the patient's prognosis and guide treatment. In immunohistochemistry, commonly used tumor markers in diagnosis of esophagus cancer are: ERCC1, TOPO1, TOP2A, TLE3, TUBB3, TS and HER2.

Slices of esophagus cancer as follows:

B2M: 11976-MM04

Immunochemical staining of human B2M in human esophageal carcinoma with mouse monoclonal antibody (15 µg/mL, formalin-fixed paraffin embedded sections).
EGFR: 10001-MM11

Immunochemical staining of human EGFR in human esophageal carcinoma with mouse monoclonal antibody (1:60, formalin-fixed paraffin embedded sections).
S100A7: 11141-MM10

Immunochemical staining of human S100A7 in human esophageal carcinoma with mouse monoclonal antibody (1:60, formalin-fixed paraffin embedded sections).
SERPINB4: 12990-R001

Immunochemical staining of human SERPINB4 in human esophageal carcinoma with rabbit monoclonal antibody (5 µg/mL, formalin-fixed paraffin embedded sections).